Evidence map›Paper›PMID 25793391›Full record

ArticlePloS one2015

Uptake of fluorescent gentamicin by peripheral vestibular cells after systemic administration.

Jianping Liu, Allan Kachelmeier, Chunfu Dai, Hongzhe Li, Peter S Steyger

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. AnFrontiers in molecular neuroscience · 2022
    Article
  7. Article
  8. Review
  9. Review
  10. Preferential Cochleotoxicity of Cisplatin.Frontiers in neuroscience · 2021
    Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Jianping LiuOregon Hearing Research Center, Oregon Health & Science University, Portland, Oregon, United States of America; Department of Otology and Skull Base Surgery, Eye Ear Nose and Throat Hospital,Fudan University, Shanghai, China.
Allan KachelmeierOregon Hearing Research Center, Oregon Health & Science University, Portland, Oregon, United States of America.
Chunfu DaiDepartment of Otology and Skull Base Surgery, Eye Ear Nose and Throat Hospital,Fudan University, Shanghai, China.
Hongzhe LiOregon Hearing Research Center, Oregon Health & Science University, Portland, Oregon, United States of America.
Peter S SteygerOregon Hearing Research Center, Oregon Health & Science University, Portland, Oregon, United States of America.
Oregon Health & Science University · USFudan University · CN

Funding

PORTLAND AREA COMMUNICATION RESEARCH CORE CENTERP30DC005983 · NIDCD · OREGON HEALTH & SCIENCE UNIVERSITY · PI NUTTALL, ALFRED L · 2003 to 2017
$9.0M
HAIR CELL RESPONSES TO OTOTOXIC DRUGSR01DC004555 · NIDCD · OREGON HEALTH & SCIENCE UNIVERSITY · PI STEYGER, PETER STEPHEN · 2001 to 2020
$6.6M
Ameliorating systemic gentamicin uptake by sensory hair cellsR01DC012588 · NIDCD · OREGON HEALTH & SCIENCE UNIVERSITY · PI STEYGER, PETER STEPHEN · 2012 to 2016
$2.0M
NIDCD NIH HHS P30 DC005983NIDCD NIH HHS P30 DC05983NIDCD NIH HHS R01 DC004555NIDCD NIH HHS R01 DC012588NIDCD NIH HHS R01 DC04555
6 · The paper itself

Abstract

objectiveIn addition to cochleotoxicity, systemic aminoglycoside pharmacotherapy causes vestibulotoxicity resulting in imbalance and visual dysfunction. The underlying trafficking routes of systemically-administered aminoglycosides from the vasculature to the vestibular sensory hair cells are largely unknown. We investigated the trafficking of systemically-administered gentamicin into the peripheral vestibular system in C56Bl/6 mice using fluorescence-tagged gentamicin (gentamicin-Texas-Red, GTTR) imaged by scanning laser confocal microscopy to determine the cellular distribution and intensity of GTTR fluorescence in the three semicircular canal cristae, utricular, and saccular maculae at 5 time points over 4 hours.

resultsLow intensity GTTR fluorescence was detected at 0.5 hours as both discrete puncta and diffuse cytoplasmic fluorescence. The intensity of cytoplasmic fluorescence peaked at 3 hours, while punctate fluorescence was plateaued after 3 hours. At 0.5 and 1 hour, higher levels of diffuse GTTR fluorescence were present in transitional cells compared to hair cells and supporting cells. Sensory hair cells typically exhibited only diffuse cytoplasmic fluorescence at all time-points up to 4 hours in this study. In contrast, non-sensory cells rapidly exhibited both intense fluorescent puncta and weaker, diffuse fluorescence throughout the cytosol. The numbers and size of fluorescent puncta in dark cells and transitional cells increased over time. There is no preferential GTTR uptake by the five peripheral vestibular organs' sensory cells. Control vestibular tissues exposed to Dulbecco's phosphate-buffered saline or hydrolyzed Texas Red had negligible fluorescence.

conclusionsAll peripheral vestibular cells rapidly take up systemically-administered GTTR, reaching peak intensity 3 hours after injection. Sensory hair cells exhibited only diffuse fluorescence, while non-sensory cells displayed both diffuse and punctate fluorescence. Transitional cells may act as a primary pathway for trafficking of systemic GTTR from the vasculature to endolymph prior to entering hair cells.

Indexed as

Fluorescent DyesAnimalsGentamicinsHair Cells, AmpullaHair Cells, VestibularMiceSemicircular DuctsTime FactorsVestibule, LabyrinthFluorescent DyesGentamicins

Identifiers

PMID25793391
PMCPMC4368668
OpenAlexW1999603030

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.